The Chemical Imbalance Theory Was Never What We Were Told

For roughly three decades, the dominant public explanation for depression was a deficiency of serotonin in the brain. Antidepressants, the story went, worked by correcting this imbalance — restoring the brain to its natural state. General practitioners explained it this way. Pharmaceutical advertising used the image of neurons with insufficient signal. Self-help books described depression as a brain chemistry problem the same way diabetes is an insulin problem. This explanation has now been largely abandoned by neuroscience. The question worth examining is what actually is known about depression's causes, what that means for treatment, and why the myth persisted so long in the first place.

How the Serotonin Hypothesis Collapsed

The serotonin hypothesis of depression predicted that reducing serotonin availability would cause depression in healthy people and that depression would correlate with measurable serotonin deficits. Neither prediction held up reliably in research. A comprehensive umbrella review published in 2022 by researchers at University College London examined the accumulated evidence from multiple research domains: serotonin metabolite levels, serotonin receptor density, serotonin transporter studies, tryptophan depletion studies, and genetic studies of serotonin-related genes. The conclusion across all domains was consistent: there was no reliable evidence for a direct relationship between serotonin activity and depression. The review received significant media attention because the scientific community had largely moved on from the serotonin hypothesis years earlier, while public understanding had not caught up. This does not mean antidepressants don't work. It means they don't work by the mechanism that was advertised. Selective serotonin reuptake inhibitors show moderate effectiveness for moderate-to-severe depression in clinical trials, with effect sizes that are meaningful but smaller than the pharmaceutical industry presented to the public. The mechanism by which they help — to the extent that they do — remains an active area of research and is likely more complex than simple serotonin restoration.

What Current Research Points Toward

The honest answer is that depression is probably not one thing. It presents differently across individuals, responds differently to interventions, and likely has multiple pathways. Current research from institutions including Harvard Medical School and the Max Planck Institute for Psychiatry has examined inflammation as a factor in a subset of depression cases — people with elevated inflammatory markers appear to respond better to anti-inflammatory interventions than to serotonergic ones. Neuroplasticity — specifically, the capacity for the brain to form new connections — is another active area, with evidence that both exercise and certain antidepressants (including ketamine) may work partly through promoting synaptic growth. Psychological factors — chronic stress, adverse childhood experiences, patterns of thought that sustain low mood — interact with biological vulnerability in ways that aren't captured by any single-mechanism story. The diathesis-stress model, which describes depression as emerging from the interaction of pre-existing vulnerability and environmental stress, is more consistent with what the research shows than any brain chemistry explanation.

The Tangent Worth Taking

The chemical imbalance story was useful for one specific purpose: reducing stigma. If depression is like diabetes — a straightforward physical malfunction requiring physical correction — it's harder to tell someone to just try harder or think more positively. That destigmatizing function had real value. The cost was that it positioned depression as a brain problem with a pharmaceutical solution, which discouraged psychotherapy, lifestyle interventions, and the kind of structural changes — in work, relationships, environment — that might address the stress component. Research from Columbia University's epidemiology department has tracked the period during which antidepressant prescriptions increased dramatically and found no corresponding decrease in depression prevalence at the population level. This is consistent with an intervention that helps some individuals while leaving the broader determinants of the problem unaddressed.

What This Should Change

None of this means avoiding antidepressants. For many people, they provide meaningful relief and make the other work more possible. What it means is that the search for a single biological cause — and a corresponding single biological fix — has been an oversimplification that has narrowed both research and treatment. The more accurate framing is that depression emerges from a combination of factors that vary by person, and effective treatment is usually a combination of approaches rather than a single correction. That's less satisfying than "your brain chemicals are off and this pill fixes them" — but it's what the evidence actually supports.